Cochrane Clinical Answers - Access Denied - What evidence from randomized controlled trials (RCTs) indicates harms of erythropoiesis-stimulating agents (ESAs) in critically ill people?

Question:What evidence from randomized controlled trials (RCTs) indicates harms of erythropoiesis-stimulating agents (ESAs) in critically ill people?

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer evaluates the harms of erythropoiesis-stimulating agents in critically ill people as reported in randomized controlled trials.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.